Cargando…
The use of dornase alfa in patients with COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society. Published by Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008799/ https://www.ncbi.nlm.nih.gov/pubmed/36966036 http://dx.doi.org/10.1016/j.jcf.2023.03.010 |
| _version_ | 1784905837719846912 |
|---|---|
| author | Ramachandram, Dinesh Sangarran Kow, Chia Siang Hasan, Syed Shahzad |
| author_facet | Ramachandram, Dinesh Sangarran Kow, Chia Siang Hasan, Syed Shahzad |
| author_sort | Ramachandram, Dinesh Sangarran |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10008799 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | European Cystic Fibrosis Society. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100087992023-03-13 The use of dornase alfa in patients with COVID-19 Ramachandram, Dinesh Sangarran Kow, Chia Siang Hasan, Syed Shahzad J Cyst Fibros Letter to the Editor European Cystic Fibrosis Society. Published by Elsevier B.V. 2023-05 2023-03-13 /pmc/articles/PMC10008799/ /pubmed/36966036 http://dx.doi.org/10.1016/j.jcf.2023.03.010 Text en © 2023 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ramachandram, Dinesh Sangarran Kow, Chia Siang Hasan, Syed Shahzad The use of dornase alfa in patients with COVID-19 |
| title | The use of dornase alfa in patients with COVID-19 |
| title_full | The use of dornase alfa in patients with COVID-19 |
| title_fullStr | The use of dornase alfa in patients with COVID-19 |
| title_full_unstemmed | The use of dornase alfa in patients with COVID-19 |
| title_short | The use of dornase alfa in patients with COVID-19 |
| title_sort | use of dornase alfa in patients with covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008799/ https://www.ncbi.nlm.nih.gov/pubmed/36966036 http://dx.doi.org/10.1016/j.jcf.2023.03.010 |
| work_keys_str_mv | AT ramachandramdineshsangarran theuseofdornasealfainpatientswithcovid19 AT kowchiasiang theuseofdornasealfainpatientswithcovid19 AT hasansyedshahzad theuseofdornasealfainpatientswithcovid19 AT ramachandramdineshsangarran useofdornasealfainpatientswithcovid19 AT kowchiasiang useofdornasealfainpatientswithcovid19 AT hasansyedshahzad useofdornasealfainpatientswithcovid19 |